Nicolae Todor

Cluj-napoca, CJ 400015, Romania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Serum TNF -α, IL-10 and IL-2 Trajectories and Outcomes in NSCLC and Melanoma Under Anti-PD-1 Therapy: Longitudinal Real-World Evidence from a Single Center.

Serum TNF -α, IL-10 and IL-2 Trajectories and Outcomes in NSCLC and Melanoma Under Anti-PD-1 Therapy: Longitudinal Real-World Evidence from a Single Center.

Journal: Current issues in molecular biology

Published: August 15, 2025

Prospective Upfront Next-Generation Sequencing for Advanced Non-Small Cell Lung Cancer: Real-World Outcomes from the Ion Chiricuță Oncology Institute.

Prospective Upfront Next-Generation Sequencing for Advanced Non-Small Cell Lung Cancer: Real-World Outcomes from the Ion Chiricuță Oncology Institute.

Journal: International journal of molecular sciences

Published: March 16, 2025

Serum Calcium Level at Diagnosis Can Predict Lethal Prostate Cancer Relapse.

Serum Calcium Level at Diagnosis Can Predict Lethal Prostate Cancer Relapse.

Journal: Journal of clinical medicine

Published: July 27, 2024

Diagnosis of Relapse of Colorectal Adenocarcinoma through CEA Fluctuation.

Diagnosis of Relapse of Colorectal Adenocarcinoma through CEA Fluctuation.

Journal: Reports (MDPI)

Published: June 09, 2024

Unselective Measurement of Tumor-to-Stroma Proportion in Colon Cancer at the Invasion Front-An Elusive Prognostic Factor: Original Patient Data and Review of the Literature.

Unselective Measurement of Tumor-to-Stroma Proportion in Colon Cancer at the Invasion Front-An Elusive Prognostic Factor: Original Patient Data and Review of the Literature.

Journal: Diagnostics (Basel, Switzerland)

Published: April 06, 2024

The value of contrast-enhanced ultrasound in cervical cancer assessed in comparison with magnetic resonance imaging.

The value of contrast-enhanced ultrasound in cervical cancer assessed in comparison with magnetic resonance imaging.

Journal: Medicine and pharmacy reports

Published: April 01, 2024

Use of Different Anti-PD-1 Checkpoint Combination Strategies for First-Line Advanced NSCLC Treatment-The Experience of Ion Chiricuță Oncology Institute.

Use of Different Anti-PD-1 Checkpoint Combination Strategies for First-Line Advanced NSCLC Treatment-The Experience of Ion Chiricuță Oncology Institute.

Journal: Cancers

Published: March 25, 2024

COVID-19 vaccine acceptance among medical students in Romania.

COVID-19 vaccine acceptance among medical students in Romania.

Journal: Journal of physiology and pharmacology : an official journal of the Polish Physiological Society

Published: March 05, 2022

Outcomes of patients with cancer infected with SARS-CoV-2: results from the Ion Chiricuţă Oncology Institute series.

Outcomes of patients with cancer infected with SARS-CoV-2: results from the Ion Chiricuţă Oncology Institute series.

Journal: ESMO open

Published: January 18, 2022

Early Deaths in Childhood Cancer in Romania-A Single Institution Study.

Early Deaths in Childhood Cancer in Romania-A Single Institution Study.

Journal: Children (Basel, Switzerland)

Published: August 15, 2021

Prognostic Factors Influencing Survival and a Treatment Pattern Analysis of Conventional Palliative Radiotherapy for Patients with Bone Metastases.

Prognostic Factors Influencing Survival and a Treatment Pattern Analysis of Conventional Palliative Radiotherapy for Patients with Bone Metastases.

Journal: Current oncology (Toronto, Ont.)

Published: July 31, 2021

Follow-up protocol for oncological patients at risk of developing multiple primary neoplasms.

Follow-up protocol for oncological patients at risk of developing multiple primary neoplasms.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: October 25, 2020

Showing 1-12 of 30

Last Updated: 09/26/2026